Kalpita Nadkar is a seasoned pharmaceutical drug product and process development professional, specializing in niche dosage forms like Pressurized Metered Dose Inhalers (pMDIs), Lyophilized drug products and CAR-T cell therapy operations. With a Master of Science in Pharmaceutical Sciences from Campbell University, USA her expertise spans innovator (GSK, BMS) and generic industries (Aurobindo Pharma and Odin Pharmaceuticals), CRO/CDMO labs, across diverse drug development portfolios.
In her current role as a Senior Manufacturing Associate at Bristol Myers Squibb, The Netherlands she oversees CAR-T Manufacturing operations. Previously, she contributed significantly in roles as a R&D Scientist at Odin Pharmaceuticals, NJ, USA and Aurobindo Pharma, NC, USA focusing on establishing cutting-edge respiratory R&D labs and formulating scalable solutions for respiratory drug products.
Her career encompasses hands-on experience in formulation, process development, and quality management across multidisciplinary domains. She has earned accolades for research presentations and demonstrated leadership in academic and extracurricular activities.
